(MedPage Today) — Psoriasis was less likely to progress to psoriatic arthritis (PsA) among patients treated with interleukin-17 (IL-17) or IL-23 inhibitors compared with those receiving tumor necrosis factor (TNF) inhibitors, a single-center study…
Source link : https://www.medpagetoday.com/dermatology/psoriasis/114256
Author :
Publish date : 2025-02-18 19:02:40
Copyright for syndicated content belongs to the linked Source.
